Serina Therapeutics (SER) Q4 2025 Earnings

13NovConfirmed
Q2 2025
Q3 2025
Q4 2025
-0.66
-0.58
-0.5
-0.43

Details

Expected EPS
-0.53
Actual EPS
-0.45
Surprise EPS
0.08
Surprise Percent
+15.09%

Description

Serina Therapeutics (SER) has reported earnings of -0.45 per share for Q4 2025.

0 Comments

Share your thoughts